Combining immunotherapy and radiotherapy in lung cancer: a promising future?

von Zhou, Jieling, Huang, Qian, Huang, Zijian, Li, Jiqiang
Veröffentlicht in J Thorac Dis (2020)

Musashi-2 is a prognostic marker for the survival of patients with cervical cancer

von Liu, Yaqiong, Fan, Yi, Wang, Xiaoyu, Huang, Zijian, Shi, Kun, Zhou, Bei
Veröffentlicht in Oncol Lett (2018)

Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer

von Du, Kunpeng, Huang, Qian, Bu, Junguo, Zhou, Jieling, Huang, Zijian, Li, Jiqiang
Veröffentlicht in Technol Cancer Res Treat (2020)

High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma

von Liu, Yaqiong, Lin, Li, Huang, Zijian, Ji, Bing, Mei, Shanshan, Lin, Ying, Shen, Zhuanxing
Veröffentlicht in Int J Clin Exp Pathol (2015)

Homology-mediated end joining-based targeted integration using CRISPR/Cas9

von Yao, Xuan, Wang, Xing, Hu, Xinde, Liu, Zhen, Liu, Junlai, Zhou, Haibo, Shen, Xiaowen, Wei, Yu, Huang, Zijian, Ying, Wenqin, Wang, Yan, Nie, Yan-Hong, Zhang, Chen-Chen, Li, Sanlan, Cheng, Leping, Wang, Qifang, Wu, Yan, Huang, Pengyu, Sun, Qiang, Shi, Linyu, Yang, Hui
Veröffentlicht in Cell Res (2017)